期刊文献+

逍遥散治疗慢性乙型肝炎68例 被引量:1

Sixty-Eight Cases with Chronic Hepatitis B Treated with Free Wanderer Powder
下载PDF
导出
摘要 目的:观察逍遥散治疗慢性乙型肝炎的临床疗效。方法:选取慢性乙型肝炎患者68例,随机分为对照组和治疗组各34例。对照组给予普通干扰素治疗,治疗组在对照组治疗的基础上加用逍遥散口服治疗。结果:治疗组HBV-DNA转阴率、HBe Ag转阴率明显高于对照组,差异有统计学意义(P均<0.05);治疗组有效率85.29%,对照组有效率61.76%,治疗组优于对照组(P<0.05)。结论:逍遥散治疗慢性乙型肝炎疗效显著。 Objective:To observe the clinical effect of Free Wanderer Powder on chronic hepatitis B. Methods :68 cases with chron- ic hepatitis B randomized into control group (34 cases ) given common interferon treatment and treatment group (34 cases) addi- tionally orally given Free Wanderer Powder. Results :The negative conversion ratios of HBV-DNA and HBeAg in treatment group were obviously higher than these in control group ; the difference had statistical significance ( P 〈 0. 05 ). The effective rate was 85.29% in treatment group while 61.76 in control group; treatment group were better than control group ( P 〈 0.05 ). Conclu- sion:Free Wanderer Powder has remarkable effect on chronic hepatitis B.
作者 季明昉
出处 《河南中医》 2015年第11期2669-2670,共2页 Henan Traditional Chinese Medicine
关键词 慢性乙型肝炎 逍遥散 HBV—DNA HB—eAg : chronic hepatitis B Free Wanderer Powder HBV-DNA HB-eAg
  • 相关文献

参考文献3

二级参考文献28

  • 1Dienstag JL.Hepatitis B virus infection.N Engl J Med,2008,359(14):1486-1500. 被引量:1
  • 2O'Connell RM,Saha SK,Vaidya SA,et al.Type Ⅰ interferon pro-duction enhances susceptibility to isteria monocytogenes infection.J Exp Med,2004,200(4):437-445. 被引量:1
  • 3Levraud JP,Boudinot P,Colin I,et al.Identification of the zebrafish IFN receptor:implications for the origin of the vertebrate IFN system.J Immunol,2007,178(7):4385-4394. 被引量:1
  • 4Sadler AJ,Williams BR.Interferon-inducible antiviral effectors.Nat Rev Immunol,2008,8(7):559-568. 被引量:1
  • 5Gabriele L,Ozato K.The role of the interferon regulatory factor(IRF)family in dendritic cell development and function.Cytokine Growth Factor Rev,2007,18(5/6):503-510. 被引量:1
  • 6Perrillo a.Benefits and risks of interferon therapy for hepatis B.Hepatology,2009,49(5 Suppl):S103-S111. 被引量:1
  • 7Marcellin P,Lau GK,Bonino F,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patients with HBeAg-negative chronic hepatitis B.N Engl J Med,2004,351(12):1206-1217. 被引量:1
  • 8Perrillo PP.Therapy of hepatitis B-viral suppresion or eradication? Hepatology,2006,43(2 Suppl 1):S182-S193. 被引量:1
  • 9Moucari R,Mackiewicz V,Lada O,et al.Early serum HBsAg drop:a strong predictor of sustained virological response to pegylated inter-fewn alfa-2a in HBeAg-negative patients.Hepatology,2009,49(4):1151-1157. 被引量:1
  • 10Mawellin P,Piratvisuth T,Brunetto M,et al.Virological and biodaemical response in patients with HBeAg-negative chronic hepati-tis B treated with peginterferon alfa-2a(4OKD)with or without lamivudine:results of 4 year-follow up.J Hepatol,2008,48:546. 被引量:1

共引文献74

同被引文献48

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部